Page last updated: 2024-08-22

pentaquine and Malaria

pentaquine has been researched along with Malaria in 16 studies

*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-199015 (93.75)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Hoda, N; Madhav, H1
CRAIGE, B; EICHELBERGER, L1
GENNIS, J; STRAUS, B2
ATCHLEY, JA; YOUNT, EH1
ALVING, AS1
SPICKNALL, CG; TERRY, LL1
MONK, JF1
LOEB, RF1
HALL, WH; LATTS, EM1
COATNEY, GR; COOPER, WC; CULWELL, WB; EYLES, DE; LINTS, HA; WHITE, WC1
ELDIN, GN; MORCOS, F1
COOPER, WC; WHITE, WC1
COGGESHALL, LT; RICE, FA1
GOBLE, FC1
COGGESHALL, LT1

Reviews

1 review(s) available for pentaquine and Malaria

ArticleYear
An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Animals; Antimalarials; Drug Development; Drug Resistance; Humans; Malaria; Molecular Targeted Therapy; Plasmodium; Protozoan Proteins; Small Molecule Libraries

2021

Other Studies

15 other study(ies) available for pentaquine and Malaria

ArticleYear
The toxicity of large doses of pentaquine (SN-13,276) a new antimalarial drug.
    The Journal of clinical investigation, 1948, Volume: 27, Issue:3 Pt1

    Topics: Aminoquinolines; Antimalarials; Chromans; Humans; Malaria; Thiosemicarbazones

1948
Evaluation of pentaquine as a cure of relapsing vivax malaria; a controlled study of 95 cases.
    Bulletin of the New York Academy of Medicine, 1948, Volume: 24, Issue:6

    Topics: Aminoquinolines; Humans; Malaria; Malaria, Vivax; Recurrence; Research Design

1948
Reactions observed during treatment with pentaquine, administered with quinacrine (atabrine) metachloridine (SN-11,437) and with sulfadiazine.
    Journal. National Malaria Society (U.S.), 1948, Volume: 7, Issue:2

    Topics: Aminoquinolines; Malaria; Quinacrine; Sulfadiazine; Sulfonamides

1948
Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria.
    Abstracts. International Congress on Tropical Medicine and Malaria (4th : 1948 : Washington, D. C.), 1948, Volume: 56, Issue:4th Congr

    Topics: Aminoquinolines; Hydroxychloroquine; Hydroxyquinolines; Malaria; Malaria, Vivax; Recurrence

1948
Combined quinine-plasmochin and quinine-pentaquine treatment of relapsing vivax malaria.
    Southern medical journal, 1948, Volume: 41, Issue:4

    Topics: Aminoquinolines; Malaria; Malaria, Vivax; Quinine; Recurrence

1948
Results of an investigation of the therapeutic action of pentaquin on acute attacks of benign tertian malaria.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1948, Volume: 41, Issue:5

    Topics: Aminoquinolines; Malaria; Malaria, Vivax

1948
Activity of a new antimalarial agent, pentaquine (SN 13,276).
    Journal of the American Medical Association, 1946, Oct-12, Volume: 132

    Topics: Aminoquinolines; Antimalarials; Chromans; Malaria; Quinolines; Thiosemicarbazones

1946
Pentaquine and quinine in the treatment of Korean vivax malaria; a controlled study in 101 patients.
    The Journal of laboratory and clinical medicine, 1955, Volume: 45, Issue:4

    Topics: Aminoquinolines; Antimalarials; Humans; Malaria; Malaria, Vivax; Quinine; Research Design

1955
Radical cure of relapsing vivax malaria with pentaquine-quinine; a controlled study.
    Annals of internal medicine, 1950, Volume: 33, Issue:6

    Topics: Aminoquinolines; Humans; Malaria; Malaria, Vivax; Quinine; Recurrence; Research Design

1950
Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria.
    Journal. National Malaria Society (U.S.), 1950, Volume: 9, Issue:3

    Topics: Aminoquinolines; Biomedical Research; Malaria; Malaria, Vivax; Sprains and Strains

1950
Pentaquine in the treatment of malaria.
    The Journal of the Egyptian Medical Association, 1952, Volume: 35, Issue:5

    Topics: Aminoquinolines; Malaria

1952
Studies in human malaria; the cure of St. Elizabeth strain vivax malaria by pentaquine-quinine, administered during acute attacks or during latency.
    Journal. National Malaria Society (U.S.), 1948, Volume: 7, Issue:4

    Topics: Aminoquinolines; Animals; Behavior, Animal; Malaria; Malaria, Vivax; Quinine; Social Behavior

1948
Cure of chronic vivax malaria with pentaquine.
    Journal of the American Medical Association, 1949, Feb-12, Volume: 139, Issue:7

    Topics: Aminoquinolines; Malaria; Malaria, Vivax

1949
Chemotherapeutic activity of certain 8-aminoquinolines, particularly pentaquine, in experimental Chagas' disease.
    The Journal of parasitology, 1949, Volume: 35, Issue:4

    Topics: Aminoquinolines; Chagas Disease; Malaria; Trypanosomiasis

1949
Cure of chronic vivax malaria with pentaquine and status of immunity thereafter.
    The Proceedings of the Institute of Medicine of Chicago, 1949, Jun-15, Volume: 17, Issue:15

    Topics: Aminoquinolines; Immunity; Malaria; Malaria, Vivax

1949